Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The suboptimal shunt design of the currently available vesico-amniotic and thoraco-amniotic shunts is likely at tributed to the risk of shunt failure, either by displacement, kinking, or obstruction, resulting in treatment failure and the need for additional fetal intervention.

Objective: To evaluate the feasibility of ultrasound-guided insertion, drainage, and short-term dislodgement risks of the novel Vortex shunt in fetal lambs with surgically induced lower urinary tract obstruction (LUTO) and pleural effusion.

Study Design: LUTO was surgically created in eight fetal lambs at a median of 71 days (range 69-72; term = 145) gestation. LUTO phenotype developed in 5, of which four survived to shunt insertion at a median of 98 days (range 97-99). The three lambs that did not develop the LUTO phenotype and the one intrauterine fetal demise underwent pleural effusion creation. In the shunted LUTO fetuses 24 h post-deployment, the location and patency of the shunt were evaluated on fetal ultrasound and autopsy. In pleural effusion fetuses, shunt deployment was followed by immediate euthanasia and obduction.

Results: The deployment of the Vortex shunt was successful in all animals. In the LUTO group, bladder drainage was observed immediately after shunt placement, and functionality was confirmed 24 h later. Immediate drainage of the pleural effusion after shunt insertion led to the resolution of the pleural effusion. Accurate shunt positioning was verified in all fetuses through post-procedural and pre-necropsy ultrasound and during autopsy. There were no complications related to the shunt deployment. The short duration between shunt placement and autopsy limits our ability to draw definitive conclusions about the long-term effects of our shunt.

Discussion: These preclinical experiments provide proof-of-concept data on the novel fetal Vortex shunt. We demonstrated short-term safety and functionality without dislodgement after 24 h of deployment. The findings are the basis for long-term preclinical efficacy and safety studies in the LUTO fetal lamb model.

Conclusion: The novel Vortex shunt was tested for short-term safety and functionality in a preclinical fetal lamb model of lower urinary tract obstruction and pleural effusion.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpurol.2025.04.027DOI Listing

Publication Analysis

Top Keywords

pleural effusion
24
vortex shunt
20
shunt
14
fetal lamb
12
lower urinary
12
urinary tract
12
tract obstruction
12
fetal
9
lamb model
8
model lower
8

Similar Publications

Fumarate hydratase (FH) deficient uterine leiomyomas account for only 0.4 % of all uterine leiomyomas. They have some unique histological characteristics and can be linked to renal cell carcinoma (HLRCC) syndrome and hereditary leiomyomatosis.

View Article and Find Full Text PDF

Hypereosinophilic syndrome (HES) is a rare disorder marked by sustained blood eosinophilia and associated tissue or organ damage in the absence of a secondary identifiable cause. Eosinophilic ascites and pleural effusion are extremely rare clinical presentations of idiopathic HES and often mimic malignancy, tuberculosis, or parasitic infections. We report a case of idiopathic HES in a 68-year-old male presenting with exudative eosinophilic ascites and pleural effusion.

View Article and Find Full Text PDF

A Novel Case of Variant and Nonimmune Hydrops Fetalis: A Case Report.

Case Rep Genet

September 2025

Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of California, Irvine, California, USA.

Nonimmune hydrops fetalis (NIHF) refers to the pathologic accumulation of fluid within the fetus due to causes other than red cell alloimmunization and now accounts for up to 90% of fetal hydrops cases. Fetal hydrops is associated with significant morbidity and mortality, and the exact prognosis is largely dependent on the underlying etiology. The most common etiologies include cardiovascular causes and chromosomal or genetic abnormalities.

View Article and Find Full Text PDF

Pleural effusions (PLEF) in pulmonary arterial hypertension (PAH), particularly in patients with isolated right heart failure, are associated with poor prognosis and increased mortality. This study investigates changes in alveolar fluid clearance (AFC) transporter expression in relation to lung fluid accumulation and PLEF formation during PAH progression, as well as the effects of terbutaline (TER) and riociguat (RIO) treatment. Using a monocrotaline (MCT)-induced pulmonary hypertension (PH) rat model, we performed a detailed molecular analysis of AFC transporter expression at different disease stages, both before and after PH development.

View Article and Find Full Text PDF

Background: Eosinophilic pleural effusion (EPE), characterized by atypical symptoms and rarity, is easily over-looked and misdiagnosed.

Methods: The patient underwent comprehensive routine laboratory tests including blood analysis and pleural effusion examination, along with B-ultrasound and computed tomography (CT) imaging. Based on combined evaluation of the epidemiological history, serum-specific parasite antibody detection and targeted Next-Generation Sequencing were performed on the clinical specimens.

View Article and Find Full Text PDF